DoW Lung Cancer Translational Research Award
Funding Opportunity Number: HT942526LCRPTRA
About the Opportunity
The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.
Distinctive Features
This funding mechanism intends to support a broad range of translational studies and allows application submission under:
- Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or
- Funding Level 2 – Pilot clinical trials of novel interventions.
Eligibility
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility".
Funding Details
- Expected Number of Awards: 6
- Estimated Total Program Funding: $9,100,000
- Cost Sharing or Matching Requirement: No
Assistance Listings: 12.420 -- Military Medical Research and Development
Key Dates
- Posted Date: May 05, 2026
- Last Updated Date: May 06, 2026
- Current Closing Date for Applications: Sep 02, 2026
- Archive Date: Oct 02, 2026
Contact Information
If you have difficulty accessing the full announcement electronically, please contact:
- eBRAP Help Desk Phone: 301-682-5507
- Email: help@eBRAP.org